Chronic Myelogenous Leukemia Treatment Market Share

Statistics for the 2023 & 2024 Chronic Myelogenous Leukemia Treatment market share, created by Mordor Intelligence™ Industry Reports. Chronic Myelogenous Leukemia Treatment share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Chronic Myelogenous Leukemia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Chronic Myelogenous Leukemia Treatment Industry Overview

The chronic myelogenous leukemia treatment market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Merck & Co. Inc, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, and Sanofi, among others.

Chronic Myelogenous Leukemia Treatment Market Leaders

  1. Bristol-Myers Squibb Co

  2. Pfizer, Inc.

  3. Teva Pharmaceutical Industries Ltd.

  4. Takeda Pharmaceutical Co. Ltd

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Chronic Myelogenous Leukemia Treatment Market Concentration